What is the ABCL stock price prediction for next 2 weeks?

According to our price prediction algorithm,AbCellera Biologics Inc. (ABCL) price will be around $2.52 in the next 2 weeks. This means it will decrease by -17.174342105263158 from the last closing price. This prediction may vary from other time period filters for ABCL stock.

What can be the highest Possible price of ABCL stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, ABCL can achieve the highest price of $2.88 which is -5.197152543049874 lower than last closing price. This prediction may vary from other time period filters for ABCL stock.

What can be the lowest Possible price of ABCL stock in next 2 weeks?

As per the forecast and algorithmic analysis, ABCL stock price can be as low as $2.15 which is -29.241957123449353 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for ABCL stock.

Will ABCL stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that ABCL stock will lose-17.174342105263158 in the next 2 weeks. This prediction may vary from other time period filters for ABCL stock.

What is ABCL stock last closing price?

Last closing price of ABCL stock was $3.04.

What is ABCL stock price prediction?

ABCL stock price prediction means predicting the future closing prices of ABCL stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of ABCL stock in a certain time period.

How we predict ABCL stock future prices?

If you are searching for ABCL stock forecast, analysis or price prediction, then you might be wondering what AbCellera Biologics Inc. (ABCL) will do in the future. Our ABCL price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This ABCL price prediction will likely answer most of your questions.

How frequent we update ABCL stock predictions?

We are updating the forecasts for the ABCL stock on daily basis.

Is using ML forecasting for ABCL stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for ABCL stock same for all the time periods?

No, the prediction for ABCL stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

AbCellera Biologics Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$3.04-3.8%Since 2 Weeks

Predicted Price$2.52-17.17%For 2 Weeks

Upper Predicted Price$2.88-5.2%For 2 Weeks

Lower Predicted Price$2.15-29.24%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of ABCL will decline by -17.17% over the next 2 Weeks and hit $2.52 by Friday, March 6, 2026. In that time frame, ABCL's share price is expected to range between $2.15 and $2.88.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Mar 6, 2026	2.16	2.55	2.96
Mar 5, 2026	2.25	2.68	3.05
Mar 4, 2026	2.26	2.65	3.05
Mar 3, 2026	2.36	2.77	3.17
Mar 2, 2026	2.34	2.74	3.17
Feb 27, 2026	2.40	2.80	3.18
Feb 26, 2026	2.53	2.92	3.33
Feb 25, 2026	2.50	2.90	3.31
Feb 24, 2026	2.58	3.01	3.39
Feb 23, 2026	2.59	2.98	3.41

ABCL shares fell -5.59% in Friday, February 20, 2026's trading session, dropping from a previous close of $3.22 to move at $3.04. The stock demonstrated notable intraday movement (see ABCL's key stats for a full breakdown), fluctuating between $2.97 and $3.17, a +6.91% trading range. While recent weeks have seen some volatility, ABCL has managed to secure a -3.80% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 4.67M shares changing hands, 2.67M more than the previous session. This amounted to $14.18M in total market activity.

Will ABCL Continue Its Downward Trend?

According to analyst ratings and projections for ABCL, AbCellera Biologics Inc. shares are anticipated to decrease by -2.79%, potentially reaching $2.96 per share by March 6, 2026. Short-term technical indicators currently suggest a neutral sentiment for ABCL. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the ABCL stock forecast, now is not the best time to buy ABCL stock because its current trading price is +19.01% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ABCL covering social and institutional perspectives.

ABCL Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into ABCL's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 38.07% to 40.34%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 44.16%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.07%, maintains a neutral outlook for the long term. Insights into ABCL's shareholder base show how institutional investors are positioning themselves during these momentum shifts

AbCellera Biologics Short-Term Forecasts

ABCL Forecast For Next 5 Days

Our algorithm anticipates AbCellera Biologics (ABCL) stock could hit $2.67 by Feb 27, 2026. This represents a -12.25% fall from today's price, following a -7.96% change over the past five days.

ABCL Forecast For Next 30 Days

Based on analysis of market trends, the outlook for AbCellera Biologics Inc. (ABCL) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $2.61, which would mean a -14.14% decrease from the current price of $3.04. Projections for this period range from a high of $3.40 to a low of $1.88.

ABCL Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for AbCellera Biologics's price over the next three months point to a rise. ABCL stock is expected to peak at $8.77 on Mar 19, 2026 before potentially dipping to $6.81 on Apr 21, 2026. On average, ABCL is likely to trade around $7.99 in the coming 90 days.

AbCellera Biologics Stock Forecast 2025

Based on our predictive models, AbCellera Biologics (ABCL) is expected to trade between $1.84 and $17.74 throughout 2026. This would result in an average price of $10.45, potentially offering investors a +243.75% return from current levels.

AbCellera Biologics Inc. Monthly Forecast 2026–2027

February 2026

According to our latest forecast models, AbCellera Biologics Inc. (ABCL) is positioned to show a strong performance in February 2026. The price is predicted to move between $8.10 and $8.41, settling at an average of $8.27. This could translate to a +172.04% gain.

March 2026

Based on current market signals, AbCellera Biologics Inc. is projected to trend march 2026. We forecast a trading range from $8.16 to $8.77, with a likely average price of $8.45. Investors could expect a potential return of +177.96%.

April 2026

Our predictive algorithms indicate AbCellera Biologics Inc. stock may see a shift in April 2026. The expected range spans $6.81–$8.53, with an average target of $7.62. This represents a positive outlook and a possible gain of +150.66%.

May 2026

Analyzing established trends, AbCellera Biologics Inc. looks set to move in May 2026. Projections place the stock between $6.93 and $9.54, averaging around $8.12. This suggests a +167.11% gain from current levels.

June 2026

Market indicators suggest AbCellera Biologics Inc. could experience notable changes during June 2026. Prices could fluctuate within $7.34 to $10.93, with a midpoint forecast of $10.08. The stock might deliver a +231.58% gain.

July 2026

Forecasting for July 2026, models estimate that AbCellera Biologics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $7.25 and $13.06, averaging $10.65. This signals a positive trajectory with potential returns around +250.33%.

August 2026

According to our latest forecast models, AbCellera Biologics Inc. (ABCL) is positioned to show a strong performance in August 2026. The price is predicted to move between $7.41 and $13.34, settling at an average of $11.47. This could translate to a +277.30% gain.

September 2026

Based on current market signals, AbCellera Biologics Inc. is projected to trend september 2026. We forecast a trading range from $7.07 to $15.86, with a likely average price of $12.54. Investors could expect a potential return of +312.50%.

October 2026

Our predictive algorithms indicate AbCellera Biologics Inc. stock may see a shift in October 2026. The expected range spans $5.91–$17.74, with an average target of $14.61. This represents a positive outlook and a possible gain of +380.59%.

November 2026

Analyzing established trends, AbCellera Biologics Inc. looks set to move in November 2026. Projections place the stock between $2.90 and $16.33, averaging around $11.80. This suggests a +288.16% gain from current levels.

December 2026

Market indicators suggest AbCellera Biologics Inc. could experience notable changes during December 2026. Prices could fluctuate within $1.84 to $13.88, with a midpoint forecast of $9.66. The stock might deliver a +217.76% gain.

January 2027

Forecasting for January 2027, models estimate that AbCellera Biologics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.61 and $14.81, averaging $10.04. This signals a positive trajectory with potential returns around +230.26%.

February 2027

According to our latest forecast models, AbCellera Biologics Inc. (ABCL) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $14.96, settling at an average of $8.73. This could translate to a +187.17% gain.

ABCL's history of dividends and stock splits also plays a role in long-term investor confidence.